Amgen Tests New Way to Make Ebola Drug to Boost Supply

October 17, 2014 4:33 PM

13 0

Amgen Inc. (AMGN) said it will work with the Bill & Melinda Gates Foundation and other groups to come up with an alternative production method for ZMapp, the promising experimental drug to treat Ebola whose supply ran out in August.

ZMapp, from Mapp Biopharmaceutical Inc. in San Diego, is currently made using tobacco plants, which can be induced to grow the three antibodies in the drug. The Gates Foundation is exploring other options amid the worst Ebola outbreak on record and last week gave Mapp a $150,000 grant to see whether...

Read more

To category page